References
- Rouge N, Buri P, Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int. J. Pharm. (1996);136, 117–139.
- Sood A, Panchagnula R. Design of controlled release delivery systems using a modified pharmacokinetic approach: a case study for drugs having a short elimination half-life and a narrow therapeutic index. Int. J. Pharm. (2003);261, 27–41.
- Brijesh SD, Avani FA, Madhabhai MP. Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation. AAPS. PharmSciTech. (2004);5, Article 34.
- Ponchel G, Irache JM. Specific and non-specific bioadhesive particulate system for oral delivery to the gastrointestinal tract. Adv. Drug Del. Rev. (1998);34, 191–219.
- Deshpande AA, Shah NH, Rhodes CT, Malick W. Development of a novel controlled-release system for gastric retention. Pharm. Res. (1997);14, 815–819.
- Chueh HR, Zia H, Rhodes CT. Optimization of sotalol floating and bioadhesive extended release tablet formulations. Drug Dev. Ind. Pharm. (1995);21, 1725–1747.
- Davis SS, Stockwell AF, Taylor MJet al. The effect of density on the gastric emptying of single and multiple unit dosage forms. Pharm. Res. (1986);3, 208–213.
- Urguhart J, Theeuwes F, inventors.Drug delivery system comprising a reservoir containing a plurality of tiny pills. US patent (1994); 4 434 153.
- Fix JA, Cargill R, Engle K. Controlled gastric emptying III. Gastric residence time of a non-disintegrating geometric shape in human volunteers. Pharm. Res. (1993);10, 1087–1089.
- Groning R, Heun G. Oral dosage forms with controlled gastrointestinal transit. Drug Dev. Ind. Pharm. (1984);10, 527–539.
- Ichikawa M, Watanabe S, Miyake Y, inventors. Granule remaining in stomach. US patent (1989); 4 844 905.
- Yang L, Esharghi J, Fassihi R. A new intra gastric delivery system for the treatment of helicobacter pylori associated gastric ulcers: in vitro evaluation. J. Control. Release. (1999);57, 215–222.
- Li S, Lin S, Daggy BP, Mirchandani HL, Chien TW. Effect of formulation variables on the floating properties of gastric floating drug delivery system. Drug Dev. Ind. Pharm. (2002);28, 783–793.
- Atyabi F, Sharma HL, Mohammad HA, Fell JT. In vivo evaluation of a novel gastric retentive formulation based on ion exchange resins. J. Control Release. (1996);42, 105–113.
- Hendeles L, Weinberger M, Johnson G. Monitoring serum theophylline levels. Clin. Pharmacokinet. (1978);3, 294–312.
- Vazquez MJ, Perez-Marcos B, Gomez-Amoza JL, Matinez-Pacheco R, Souto C, Concheiro A. Influence of technological variables on drug release of drug from hydrophilic matrices. Drug Dev. Ind. Pharm. (1992);18, 1355–1375.
- Ford JL, Rubinstein MH, Hogan JE. Formulation of sustained release promethazine hydrochloride tablet using HPMC matrices. Int. J. Pharm. (1985);24, 327–337.
- Rosa JCM, Zia H, Christopher TR. Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int. J. Pharm. (1994);105, 65–70.
- Chu JS, Amidon GL, Weiner ND, Goldberg AH. Mixture experimental design in the development of a mucoadhesive gel formulation. Pharm. Res. (1991);8, 1401–1407.
- Garcia Gonzalez N, Kellaway IW, Blanco-Fuente H, Anguiano-Igea S, Blanco-Mendez J. Design and evaluation of buccoadhesive metoclopramide hydrogels composed of poly (acrylic acid) crosslinked with sucrose. Int. J. Pharm. (1993);100, 65–70.
- Campos-Aldrete ME, Villafuerte-Robles L. Influence of the viscosity grade and particle size of HPMC on metronidazole release from matrix tablets. Eur. J. Pharm. Biopharm. (1997);43, 173–178.
- Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. (1985);60, 110–111.
- Ritger PL, Peppas NA. A simple equation for description of solute release. II Fickian and anomalous release from swellable devices. J. Control. Release. (1987);5, 37–42.